These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 29998146)
1. Development of an Kamiya Y; Ota S; Tanaka Y; Yamashita K; Takaki A; Ito S Asia Ocean J Nucl Med Biol; 2018; 6(2):129-138. PubMed ID: 29998146 [TBL] [Abstract][Full Text] [Related]
2. Uptake Index of Kamiya Y; Ota S; Okumiya S; Yamashita K; Takaki A; Ito S Asia Ocean J Nucl Med Biol; 2017; 5(1):37-43. PubMed ID: 28840137 [TBL] [Abstract][Full Text] [Related]
3. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases. Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701 [TBL] [Abstract][Full Text] [Related]
4. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index. Sakamoto F; Shiraishi S; Ogasawara K; Tsuda N; Nakagawa M; Tomiguchi S; Yamashita Y Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068 [TBL] [Abstract][Full Text] [Related]
5. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913 [TBL] [Abstract][Full Text] [Related]
6. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394 [TBL] [Abstract][Full Text] [Related]
7. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases. Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151 [TBL] [Abstract][Full Text] [Related]
8. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses. Lamotte G; Morello R; Lebasnier A; Agostini D; Defer GL BMC Neurol; 2015 May; 15():83. PubMed ID: 25971430 [TBL] [Abstract][Full Text] [Related]
9. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features. Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991 [TBL] [Abstract][Full Text] [Related]
10. Absolute quantitation of sympathetic nerve activity using [ Saito S; Nakajima K; Komatsu J; Shibutani T; Wakabayashi H; Mori H; Takata A; Ono K; Kinuya S EJNMMI Rep; 2024 Jun; 8(1):15. PubMed ID: 38822219 [TBL] [Abstract][Full Text] [Related]
11. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438 [TBL] [Abstract][Full Text] [Related]
13. Sympathetic Nakajima K; Matsumura T; Komatsu J; Wakabayashi H; Ono K; Kinuya S Ann Nucl Med; 2024 Oct; 38(10):814-824. PubMed ID: 38869809 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases. Nakae I; Hayashi H; Mitsunami K; Horie M Ann Nucl Med; 2013 Oct; 27(8):737-47. PubMed ID: 23728513 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT. Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141 [TBL] [Abstract][Full Text] [Related]
16. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506 [TBL] [Abstract][Full Text] [Related]
17. Influence of antidepressant use on Adaniya S; Takahashi M; Koyama K; Ogane K; Momose T Ann Nucl Med; 2022 May; 36(5):488-494. PubMed ID: 35184216 [TBL] [Abstract][Full Text] [Related]
18. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056 [TBL] [Abstract][Full Text] [Related]
19. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study. Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C; Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636 [TBL] [Abstract][Full Text] [Related]